Farzin Mostafa, Molls Michael, Kampfer Severin, Astner Sabrina, Schneider Ralf, Roth Karin, Dobrei Michaela, Combs Stephanie, Straube Christoph
Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Science, Tehran, Iran.
Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675, Munich, Germany.
J Neurooncol. 2016 May;127(3):597-606. doi: 10.1007/s11060-016-2071-7. Epub 2016 Feb 6.
In this retrospective evaluation, we correlated radiation dose parameters with occurrence of optical radiation-induced toxicities. 213 meningioma patients received radiation between 2000 and 2013. Radiation dose and clinical data were extracted from planning systems and patients' files. The range of follow-up period was 2-159 months (median 75 months). Median age of patients was 60 years (range 23-86). There were 163 female and 50 male patients. In 140 cases, at least one of the neuro-optic structures (optic nerves and chiasm) was inside the irradiated target volumes. We found 15 dry eye (7 %) and 24 cataract (11.2 %) cases. Median dose to affected lachrymal glands was 1.47 Gy and median dose to affected lenses was 1.05 Gy. Age and blood cholesterol level in patients with cataract were significantly higher. Patients with dry eye were significantly older. Only two patients with visual problems attributable to radiation treatment were seen. They did not have any risk factors. Maximum and median delivered doses to neuro-optic structures were not higher than 57.30 and 54.60 Gy respectively. Low percentages of cases with radiation induced high grade optic toxicities show that modern treatment techniques and doses are safe. In very few patients with optic side effects, doses to organs at risk were higher than the defined constraint doses. This observation leads to the problem of additional risk factors coming into play. The role of risk factors and safety of higher radiation doses in high grade meningiomas should be investigated in more comprehensive studies.
在这项回顾性评估中,我们将辐射剂量参数与光辐射诱发毒性的发生情况进行了关联分析。2000年至2013年间,213例脑膜瘤患者接受了放射治疗。从治疗计划系统和患者病历中提取了辐射剂量和临床数据。随访期为2至159个月(中位数为75个月)。患者的中位年龄为60岁(范围为23至86岁)。其中女性患者163例,男性患者50例。在140例病例中,至少一个神经视结构(视神经和视交叉)位于照射靶区内。我们发现15例干眼症(7%)和24例白内障(11.2%)。受影响泪腺的中位剂量为1.47 Gy,受影响晶状体的中位剂量为1.05 Gy。白内障患者的年龄和血胆固醇水平显著更高。干眼症患者的年龄显著更大。仅发现2例因放射治疗导致视力问题的患者。他们没有任何危险因素。神经视结构的最大和中位给予剂量分别不高于57.30 Gy和54.60 Gy。辐射诱发的高级别视神经毒性病例的比例较低,表明现代治疗技术和剂量是安全的。在极少数出现视神经副作用的患者中,危及器官的剂量高于规定的限制剂量。这一观察结果引发了其他危险因素发挥作用的问题。在更全面的研究中应调查高级别脑膜瘤中危险因素和更高辐射剂量安全性的作用。